April 11, 2013 — An estimated 5,000 nuclear medicine and molecular imaging professionals are expected to gather in June for the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) to discuss the latest advances in radiotracers, imaging modalities, radionuclide therapies and quality.
The meeting will be held June 8-12 in Vancouver, British Columbia, Canada. This year’s meeting marks the 60th anniversary of the SNMMI Annual Meeting.
“Our first meeting was held in Seattle, Wash., in 1954, and was reported to have had 109 attendees who heard 13 scientific presentations and one panel discussion,” said Peter Herscovitch, M.D., chair of SNM’s Scientific Program Committee (SPC).
Today, the SNMMI Annual Meeting offers education opportunities for physicians, technologists, pharmacists, physicists, scientists and laboratory professionals in the nuclear medicine and molecular imaging fields. More than 110 expert-led continuing education sessions will be held on topics including emerging PET radiotracers, dementia, neuroendocrine tumor imaging, novel targeted radiopharmaceutical therapies and hybrid imaging. Several other special courses will be held, including 11 categorical sessions, 22 self-assessment modules, a two-day CT case review workshop and a new Education Forum designed specifically for nuclear medicine program directors. The Annual Meeting will also feature a special session honoring Henry N. Wagner, Jr., M.D., nuclear medicine pioneer and visionary, who died last year.
SNMMI will again offer its Virtual Meeting for those who missed sessions of interest at the meeting or those unable to travel to Vancouver. The Virtual Meeting will include 70 of the most popular sessions, captured on video and available to view online or on a mobile device.
For more information: www.snmmi.org/am2013